Combinations with RVD Beyond Daratumumab  Data with ixazomib, revlimid, & dexamethasone

Combinations with RVD Beyond Daratumumab Data with ixazomib, revlimid, & dexamethasone

hematologydebates

1 year
190 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Paul G. Richardson, MD, explains Combinations with RVD Beyond Daratumumab Data with ixazomib, revlimid, & dexamethasone at Imedex Great Debates 2018.
Up Next Autoplay
Incorporating Different Schedules into Combinations  Use minimum active dose
Incorporating Different Schedules into Combinations Use minimum active dose
Category: Hematologic Malignancies
298 Views
hematologydebates 1 year
Quadruple Agents in Relapse Refractory Myeloma  Capitalizing on synergy & lack of toxicities
Quadruple Agents in Relapse Refractory Myeloma Capitalizing on synergy & lack of toxicities
Category: Hematologic Malignancies
232 Views
hematologydebates 1 year
Adding to Lenalidomide to Make it Work Better  Prednisone inhibitors, carfilzomib, and bortezomib
Adding to Lenalidomide to Make it Work Better Prednisone inhibitors, carfilzomib, and bortezomib
Category: Hematologic Malignancies
202 Views
hematologydebates 1 year
One Size Does Not Fit All in Myeloma   Clonal Tiding & Complex Heterogeneity
One Size Does Not Fit All in Myeloma Clonal Tiding & Complex Heterogeneity
Category: Hematologic Malignancies
262 Views
hematologydebates 1 year
Early Transplant Confers PFS Benefit, but Not Overall  Stem cell transplant is an option
Early Transplant Confers PFS Benefit, but Not Overall Stem cell transplant is an option
Category: Hematologic Malignancies
186 Views
hematologydebates 1 year
RVD-Lite Mission Treating Over 50 Patients Regimen of Bortezomib, lenalidomide, steroids
RVD-Lite Mission Treating Over 50 Patients Regimen of Bortezomib, lenalidomide, steroids
Category: Hematologic Malignancies
51 Views
hematologydebates 1 year
Selinexor is a Novel Mechanism of Action  Venetoclax Serves a Challenging Population
Selinexor is a Novel Mechanism of Action Venetoclax Serves a Challenging Population
Category: Chronic Lymphocytic Leukemia
140 Views
hematologydebates 1 year
Role of Venetoclax in Plasma Cell Leukemia Excellent partner drug with non-overlapping toxicities
Role of Venetoclax in Plasma Cell Leukemia Excellent partner drug with non-overlapping toxicities
Category: Chronic Lymphocytic Leukemia
110 Views
hematologydebates 1 year
Powerful new IMiDs, CC-220 & CC-92480 Importance of Small Molecules in advanced trials
Powerful new IMiDs, CC-220 & CC-92480 Importance of Small Molecules in advanced trials
Category: Chronic Lymphocytic Leukemia
252 Views
hematologydebates 1 year